We need you! Join our contributor community and become a WikEM editor through our open and transparent promotion process.
Ticlopidine
From WikEM
Contents
Administration
- Type: Antiplatelet
- Dosage Forms:
- Routes of Administration: Oral
- Common Trade Names: Ticlid
Adult Dosing
- 250mg PO BID
Pediatric Dosing
Safety/efficacy not established
Special Populations
- Pregnancy Rating: B
- Lactation risk: Infant risk cannot be ruled out
- Renal dosing:
- Hepatic dosing: may have increased bleeding risk
Contraindications
- Allergy to class/drug
- Hematopoietic disorders (e.g. neutropenia, thrombocytopenia, or past history of TTP or aplastic anemia)
- Active bleeding
- Severe liver disease
Adverse Reactions
Serious
- Aplastic anemia, pancytopenia, agranulocytosis, pancytopenia, thrombocytopenia, neutorpenia, TTP
Common
- Rash
- Nausea, diarrhea, abdominal pain
- Hemorrhage
- Leukopenia
- Dizziness
Pharmacology
- Half-life: 4-5 days
- Metabolism: Hepatic
- Excretion: Mostly renal
Mechanism of Action
- Prevents ADP from stimulating platelet-fibrinogen binding, blocking platelet aggregation
